Pharma Pulse 7/5/24: Annual Life Sciences Good Manufacturing Practices Master Class 2024, FDA Grants Marketing Authorization for Rapid Hep C Test

What Needs to be Done to Cover GLP-1?

In this part of his Pharmaceutical Executive video interview, Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, and what needs to be done for GLP-1s to be covered.

FDA Grants Marketing Authorization for Rapid Hepatitis C Test

The test can be performed in settings that operate under the Clinical Laboratory Improvement Amendments waiver, including community pharmacies.

Apple Poised to Get OpenAI Board Observer Role as Part of AI Pact

Apple Inc. will get an observer role on OpenAI’s board as part of a landmark agreement announced last month, further tightening ties between the once-unlikely partners.

Annual Life Sciences GMP (Good Manufacturing Practices) Master Class 2024

The "Annual GMP Master Class 2024" training has been added to ResearchAndMarkets.com's offering.

cGMPs or Current Good Manufacturing Practices is a general encompassing term for the regulations that the control of all facets of life sciences manufacturing processes and facilities particularly pharmaceutical products.

Cencora on LinkedIn

How can distributors ensure urgent drug recalls are handled as efficiently as possible?

Our Medication Trays used with RFID technology solve data management issues in the drug recall process, which saves time and effort for hospital pharmacies. Read our VP of Product Management, Global Products & Solutions Beth Riggio’s interview about it in Pharmaceutical Executive: https://ow.ly/iFrv50SuzaA

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs